Abiopharma

🔍 Markovich John M. (Executive)

Company: D-Wave Quantum Inc. (QBTS)

Report Date: 2026-06-12

Detailed Transactions and Holdings:

• Sold 46,043 shares of Common Stock, par value $0.0001 per share ("Common Stock") at $24.01 per share (Direct)
  Date: 2026-06-12 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,342,820.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 100,000 shares of Common Stock, par value $0.0001 per share ("Common Stock") at $25.75 per share (Direct)
  Date: 2026-06-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,242,820.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 100,000 shares of Common Stock, par value $0.0001 per share ("Common Stock") at $25.68 per share (Direct)
  Date: 2026-06-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,142,820.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 10,584 shares of Common Stock, par value $0.0001 per share ("Common Stock") at $23.37 per share (Direct)
  Date: 2026-06-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 1,132,236.00 | transaction_form_type: 4 | Footnotes: F3, F2

Footnotes:

• F1: The sales price reported is the weighted average sale price for the number of shares of Common Stock sold. These shares were sold in multiple transactions at prices ranging from $24.00 to $24.10, inclusive. Full information regarding the number of shares sold at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.
• F2: Includes 420,872 unvested restricted stock units.
• F3: Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.